rs1057519880

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000246785.7(BCL2L12):​c.-201C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,458,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

BCL2L12
ENST00000246785.7 5_prime_UTR_premature_start_codon_gain

Scores

3
2
14

Clinical Significance

Likely pathogenic no assertion criteria provided P:2

Conservation

PhyloP100: 1.21

Publications

11 publications found
Variant links:
Genes affected
BCL2L12 (HGNC:13787): (BCL2 like 12) This gene encodes a member of a family of proteins containing a Bcl-2 homology domain 2 (BH2). The encoded protein is an anti-apoptotic factor that acts as an inhibitor of caspases 3 and 7 in the cytoplasm. In the nucleus, it binds to the p53 tumor suppressor protein, preventing its association with target genes. Overexpression of this gene has been detected in a number of different cancers. There is a pseudogene for this gene on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
IRF3 (HGNC:6118): (interferon regulatory factor 3) This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes. The protein plays an important role in the innate immune response against DNA and RNA viruses. Mutations in this gene are associated with Encephalopathy, acute, infection-induced, herpes-specific, 7. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24721393).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF3NM_001571.6 linkc.-253G>A upstream_gene_variant ENST00000377139.8 NP_001562.1 Q14653-1
BCL2L12NM_138639.2 linkc.-201C>T upstream_gene_variant ENST00000246784.8 NP_619580.2 Q9HB09

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF3ENST00000377139.8 linkc.-253G>A upstream_gene_variant 1 NM_001571.6 ENSP00000366344.3 Q14653-1
BCL2L12ENST00000246784.8 linkc.-201C>T upstream_gene_variant 1 NM_138639.2 ENSP00000246784.4 A0A087WSV0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000399
AC:
1
AN:
250912
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1458502
Hom.:
0
Cov.:
32
AF XY:
0.00000414
AC XY:
3
AN XY:
724766
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33412
American (AMR)
AF:
0.00
AC:
0
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39578
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53168
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1109436
Other (OTH)
AF:
0.00
AC:
0
AN:
60198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Squamous cell carcinoma of the skin Pathogenic:1
May 31, 2016
Database of Curated Mutations (DoCM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Malignant melanoma of skin Pathogenic:1
May 31, 2016
Database of Curated Mutations (DoCM)
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.0016
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
16
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.040
T;T;T;T;.;T
Eigen
Benign
0.19
Eigen_PC
Benign
0.20
FATHMM_MKL
Benign
0.0079
N
LIST_S2
Benign
0.78
T;T;T;T;T;.
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.25
T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.69
N;.;.;.;N;N
PhyloP100
1.2
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-3.0
.;.;.;.;D;D
REVEL
Benign
0.22
Sift
Pathogenic
0.0
.;.;.;.;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D
Polyphen
1.0
D;.;.;.;.;D
Vest4
0.20
MutPred
0.45
Loss of disorder (P = 0.0034);Loss of disorder (P = 0.0034);Loss of disorder (P = 0.0034);Loss of disorder (P = 0.0034);Loss of disorder (P = 0.0034);Loss of disorder (P = 0.0034);
MVP
0.66
MPC
0.19
ClinPred
0.93
D
GERP RS
3.6
PromoterAI
-0.47
Neutral
Varity_R
0.27
gMVP
0.088

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057519880; hg19: chr19-50169132; COSMIC: COSV55862483; COSMIC: COSV55862483; API